RUPATADINE
- Empirical Formula: C26H26ClN3
- Molecular Weight: 415.96
- MDL number: MFCD00868381
What is RUPATADINE?
Clinical Use
Antihistamine
Drug interactions
Potentially hazardous interactions with other drugs
Antibacterials: concentration increased by
clarithromycin and erythromycin - use with caution.
Antifungals: concentration increased by itraconazole,
ketoconazole, posaconazole and voriconazole -
avoid; use fluconazole with caution.
Antivirals: concentration possibly increased by
ritonavir and other protease inhibitors - avoid.
Grapefruit juice: concentration increased - avoid.
Lipid-lowering agents: use in combination with
statins with caution.
Ciclosporin, sirolimus, tacrolimus - concentration
possibly increased by rupatadine.
Metabolism
Mainly metabolised by the cytochrome P450 (CYP 3A4) enzyme pathway. The amounts of unaltered active substance found in urine and faeces were insignificant. This means that rupatadine is almost completely metabolised.
Safety information for RUPATADINE
New Products
2-(2-Chlorophenyl)glycine Propiolic Acid 1-(3-Hydroxy-4-methoxyphenyl)-2-nitroethene (±)-amino(2-fluorophenyl)acetic acid trans-3-Benzyloxy-4-methoxy-beta-nitrostyrene 1-Pentadecanol 4-(4-Αminophenyl)-3-Morpholinone 3-Morpholino-1-(4-(2-oxopiperidin-1-yl) phenyl)-5,6-dihyropyridin-2-(1H)-one 1-(4-Aminophenyl)-3-morpholino-5,6-dihydropyridin-2(1H)-one N-cyanoacetylurethane 1H-IndazoleYou may like
-
40216-83-9 trans-4-Hydroxy-L-proline methyl ester hydrochloride 98+View Details
40216-83-9 -
471-25-0 Propiolic Acid 98+View Details
471-25-0 -
84145-28-8 98+View Details
84145-28-8 -
trans-3-Benzyloxy-4-methoxy-beta-nitrostyrene 98+View Details
63909-29-5 -
2-(2-Chlorophenyl)glycine 88744-36-9 98+View Details
88744-36-9 -
40216-83-9 trans-4-Hydroxy-L-proline methyl ester hydrochloride 98+View Details
40216-83-9 -
629-76-5 98+View Details
629-76-5 -
1-(3-Hydroxy-4-methoxyphenyl)-2-nitroethene 98+View Details
39816-35-8
